APA (7th ed.) Citation

SL, M., & S, L. (2020). Emerging benefits of Fc fusion technology in the context of recombinant factor VIII replacement therapy. Haemophilia : the official journal of the World Federation of Hemophilia, 26(6), 958. https://doi.org/10.1111/hae.14123

Chicago Style (17th ed.) Citation

SL, Meeks, and Lacroix-Desmazes S. "Emerging Benefits of Fc Fusion Technology in the Context of Recombinant Factor VIII Replacement Therapy." Haemophilia : The Official Journal of the World Federation of Hemophilia 26, no. 6 (2020): 958. https://doi.org/10.1111/hae.14123.

MLA (9th ed.) Citation

SL, Meeks, and Lacroix-Desmazes S. "Emerging Benefits of Fc Fusion Technology in the Context of Recombinant Factor VIII Replacement Therapy." Haemophilia : The Official Journal of the World Federation of Hemophilia, vol. 26, no. 6, 2020, p. 958, https://doi.org/10.1111/hae.14123.